Diferencia entre revisiones de «Template:Pyelonephritis antibiotics»

Sin resumen de edición
Sin resumen de edición
Línea 1: Línea 1:
''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus]], [[S. saprophyticus]]''
''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus]], [[S. saprophyticus]]''
====Outpatient====
====Outpatient====
''Give one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is < 80%
''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''
*[[Ciprofloxacin]] 500mg BID x 7 days OR
*[[Ciprofloxacin]] 500mg BID x 7 days OR
*[[Cefpodoxime]] 200 mg BID x10-14 days OR<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>
*[[Cefpodoxime]] 200 mg BID x10-14 days OR<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>

Revisión del 16:14 20 abr 2015

Treatment is targeted at E. coli, Enterococcus, Klebsiella, Proteus, S. saprophyticus

Outpatient

Consider one dose of Ceftriaxone 1g IV or Gentamycin 7mg/kg IV if the regional susceptibility of TMP/SMX or Fluoroquinolones is <80%

Inpatient Options

  1. Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.
  2. Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.